Published in Prog Neuropsychopharmacol Biol Psychiatry on May 01, 1995
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Differentiation of enteropathogenic Campylobacter. J Clin Pathol (1980) 9.66
'1001' Campylobacters: cultural characteristics of intestinal campylobacters from man and animals. J Hyg (Lond) (1980) 6.72
Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nat Genet (1993) 3.40
The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell (1992) 3.20
Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet (1996) 2.92
Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry (1999) 2.80
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry (1992) 2.60
Genetic linkage between X-chromosome markers and bipolar affective illness. Nature (1987) 2.44
Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J Neurosurg (1998) 2.31
Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol (2007) 2.12
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry (2002) 1.98
The solution structure of human epidermal growth factor. Nature (1987) 1.94
Etiology of acute conjunctivitis in children. J Pediatr (1981) 1.92
Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet (1995) 1.90
Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry (2006) 1.89
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res (2008) 1.84
Subtyping major depressive disorder. Psychother Psychosom (2010) 1.76
Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Mol Psychiatry (2000) 1.74
Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry (1998) 1.71
X-linkage and genetic heterogeneity in bipolar-related major affective illness: reanalysis of linkage data. Ann Hum Genet (1982) 1.71
Distinct syndromes of hemineglect. Arch Neurol (1992) 1.71
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucleic Acids Res (1990) 1.69
Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet (2000) 1.68
Key residues involved in calcium-binding motifs in EGF-like domains. Nature (1991) 1.68
Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature (1988) 1.67
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry (1997) 1.66
Campylobacter bacteraemia in England and Wales, 1981-91. Epidemiol Infect (1993) 1.64
Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry (2005) 1.54
Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. J Clin Psychiatry (1996) 1.53
Neuroendocrine evidence for age-related decline in central serotonergic function. Neuropsychopharmacology (1999) 1.49
Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls. Psychother Psychosom (2011) 1.46
Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry (2004) 1.46
A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry (2000) 1.45
Three-dimensional structure of a complement control protein module in solution. J Mol Biol (1991) 1.44
Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res (2000) 1.43
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry (2006) 1.43
Drosophila dumpy is a gigantic extracellular protein required to maintain tension at epidermal-cuticle attachment sites. Curr Biol (2000) 1.42
A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet (2001) 1.42
Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells. Hum Mol Genet (2010) 1.42
Ethical issues in genetic linkage studies of psychiatric disorders. Br J Psychiatry (1992) 1.40
[Malignant transformation of abdominal wall endometriosis: a new case report]. J Gynecol Obstet Biol Reprod (Paris) (2006) 1.40
Biological psychiatry in Israel: approaching the challenge of maturity. Isr J Psychiatry Relat Sci (1995) 1.39
A comparison of pulmonary function in male smokers and nonsmokers. Am Rev Respir Dis (1976) 1.39
Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients. Biol Psychiatry (1991) 1.38
Absence of prion protein mutation in bipolar manic-depressive patients. Br J Psychiatry (1992) 1.36
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry (2001) 1.29
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum (1994) 1.28
Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum (1981) 1.27
Phleomycin resistance encoded by the ble gene from transposon Tn 5 as a dominant selectable marker in Saccharomyces cerevisiae. Mol Gen Genet (1987) 1.27
The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO J (1990) 1.26
Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Res Bull (2008) 1.26
Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am J Psychiatry (1998) 1.25
A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia. Am J Psychiatry (1985) 1.24
Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum (1990) 1.21
The Drosophila melanogaster Suppressor of deltex gene, a regulator of the Notch receptor signaling pathway, is an E3 class ubiquitin ligase. Genetics (1999) 1.20
Trafficked female sex workers awaiting deportation: comparison with brothel workers. Arch Womens Ment Health (2004) 1.20
The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry (2001) 1.20
Environmental stress and psychiatric illness. Biomed Pharmacother (2000) 1.19
Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus. Horm Metab Res (2008) 1.19
Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol Psychiatry (2003) 1.19
The intrinsic connectivity distribution: a novel contrast measure reflecting voxel level functional connectivity. Neuroimage (2012) 1.17
Irreducible lateral dislocation of the patella: a case report. Orthopedics (1984) 1.17
Ritual female genital surgery among Bedouin in Israel. Arch Sex Behav (1995) 1.15
Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiol Lett (1998) 1.15
Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry (2006) 1.14
Genetic analysis of Tourette syndrome suggesting major gene effect. Am J Hum Genet (1981) 1.14
The motivation and mental health of sex workers. J Sex Marital Ther (2002) 1.14
GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol (2002) 1.13
Mortality in systemic sclerosis (scleroderma). Q J Med (1992) 1.12
Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions. Mol Psychiatry (2009) 1.12
Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results. Behav Pharmacol (2008) 1.12
Genetic characterization of the Drosophila melanogaster Suppressor of deltex gene: A regulator of notch signaling. Genetics (1998) 1.12
Treatment of bipolar depression. N Engl J Med (2007) 1.11
Secondary structure of a complement control protein module by two-dimensional 1H NMR. Biochemistry (1991) 1.11
Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry (1997) 1.11
Schizoaffective illness, schizophrenia and affective disorders: morbidity risk and genetic transmission. Acta Psychiatr Scand (1982) 1.10
Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav Pharmacol (2007) 1.09
Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet (1998) 1.09
Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet (2000) 1.08
Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. J Clin Psychiatry (1994) 1.08
Variability of skin scores and clinical measurements in scleroderma. J Rheumatol (1995) 1.08
The management of priapism in sickle cell anemia. J Urol (1978) 1.08
A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. Am J Hum Genet (1999) 1.07
Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry (2000) 1.07
Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc. Arch Dermatol (2000) 1.06
Isolation of proteoglycan-specific T lymphocytes from patients with ankylosing spondylitis. Cell Immunol (1988) 1.05
Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol Psychiatry (1998) 1.05
Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. Int J Neuropsychopharmacol (2005) 1.05
Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Pharmacogenomics J (2005) 1.04